Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost-PPDS in Glaucoma/OHT (CORE)
NCT00650702Phase 2Completed
- Sponsor
- Mati Therapeutics
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Mati Therapeutics. Started Mar 2008; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00650702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650702.